CWAM
ISEE

Columbia Wanger Asset Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Columbia Wanger Asset Management’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-264,000
Closed -$7.84M – 313
2013
Q3 		$7.84M Buy
+264,000
New +$7.49M 0.03% 277

Other funds holding ISEE

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
CV
Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
ICAP
Independence Capital Asset Partners Denver, Colorado $9.3M AUM 28.89% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
JCG
JHL Capital Group Chicago, Illinois $805M AUM 50.84% 1-Year Est. Return

Columbia Wanger Asset Management's ISEE Position: Q4 2013 in Review

Columbia Wanger Asset Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q4 2013, closing a stake of 264,000 shares — an estimated $7.84M sold.

Columbia Wanger Asset Management first reported a position in ISEE in Q3 2013 and held it in 1 quarter. The position peaked at $7.84M in Q3 2013. 64 funds tracked by Wall St. Rank hold ISEE as of Q4 2013.

  • Columbia Wanger Asset Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q4 2013 after selling out during the quarter.
  • Columbia Wanger Asset Management sold 264,000 IVERIC bio, Inc. Common Stock shares in Q4 2013, an estimated $7.84M.
  • Columbia Wanger Asset Management first reported a position in IVERIC bio, Inc. Common Stock in Q3 2013 and held it in 1 quarter.
  • Columbia Wanger Asset Management's IVERIC bio, Inc. Common Stock position peaked at $7.84M in Q3 2013.
  • 64 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2013.

Based on Columbia Wanger Asset Management's 13F filing for Q4 2013, filed 29 Jan 2014.